Stocks
Agios Pharmaceuticals (AGIO) EBITDA US GAAP (year values) |
|||||||||
| FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | LTM ? | CAGR 5 years ? | |||
| EBITDA, bln rub | ? | -337.7 | -380.5 | -384.9 | -420.1 | -408.6 | -470.3 | ||
| Changes by years, y/y, % | +9% | +13% | +1% | +9% | -3% | +5.6% | |||
Agios Pharmaceuticals. EBITDA US GAAP, bln rub
Agios Pharmaceuticals. EBITDA US GAAP, changes, %
Agios Pharmaceuticals. EBITDA US GAAP, sum by quarters, bln rub
Agios Pharmaceuticals (AGIO) EBITDA US GAAP (quarter values) |
||||||||
| FY2025Q1 | FY2025Q2 | FY2025Q3 | FY2025Q4 | FY2026Q1 | LTM ? | |||
| EBITDA, bln rub | ? | -105.4 | -110.8 | -102.1 | -107.8 | -97.7 | -470.3 | |
| Changes by years, y/y, % | +16% | +6% | +1% | -13% | -7% | |||
| Changes by quarters, q/q, % | -15% | +5% | -8% | +6% | -9% | |||
